Micropep kickstarts global regulatory registration of its peptide-based biofungicide
France- and US-based ag biotech company Micropep is closer to commercializing its peptide-based biofungicide Promisin af…
科迪华2026上半年净销售额增至112.8亿美元：种子业务增长4%、植保增长3%
世界农化网中文网报道：7月31日，科迪华公布了截至2026年6月30日的第二季度及上半年财务业绩。得益于种子业务在最新需求旺盛的种质与性状技术方面的持续价值兑现（包括授权收入的增长），以及植保业务新产品需求与运营卓越的推动，公司上半年表现强劲，并据此上调了2026年全年业绩指引。同时，科迪华确认将于2026年10月1日如期完成分拆计划。
Ipsen quietly returns cancer drug IPN01194 to AGV Discovery
Why it matters: The decision removes one of Ipsen’s two experimental MAPK-pathway inhibitors for solid tumours and returns a clinical-stage programme to the small French biotech that discovered it.
Sobi’s dealmaker CEO exits for BioNTech
Why it matters: BioNTech’s decision provides a powerful external endorsement of Oelkers’ record at Sobi. Oelkers did not create Sobi’s scientific foundations, but he built a much larger commercial and dealmaking organization around them, expanding the company in the U.S. and adding a succession of acquired and licensed rare disease products. BioNTech is now hiring him for a similar company-building challenge: scaling an innovation-driven biotech as it prepares to launch multiple products.
Upstream Biotechnology raises seed funding for ‘on-demand’ crop defense tech
Plants already have the tools to respond to a range of biotic and abiotic threats. The problem, says North Carolina-base…
Evolutionarily Diverse Organisms Switch Genes on Simply and Switch Them off Dynamically
The signals that cells use to switch genes on have remained almost unchanged across two billion years of evolution, but the ones used to switch genes off vary dramatically from one branch of life to another, according to a new study by researchers at the Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST).
利尔化学接受多家机构调研，回应与新股东华润双鹤的合作模式
世界农化网中文网报道：近日，利尔化学股份有限公司接受申万宏源、永赢基金等特定对象调研，公司董事长尹英遂、副总经理/董事会秘书刘军、董事会办公室主任/证券事务代表靳永恒，以及及董事会办公室刘妤出席本次投资者关系活动，主要交流问题如下：
Weed control, disease, and drainage are top pain points for farmers in 2026, says Grand Farm
“Innovation has to start with listening,” says Dr. William Aderholdt, executive director of US-based agtech …
Receptor.AI and Sethera Plan to Create Closed-Loop Discovery and Optimization Workflow for Difficult Therapeutic Targets
Receptor.AI and Sethera partner to create a closed-loop drug discovery workflow. Sethera will generate and experimentally screen architecture-diverse polymacrocyclic peptide libraries. Receptor.AI will apply physics-based modeling, artificial intelligence, and multiparameter optimization to interpret sequence, architecture, enrichment, and activity data; develop binding hypotheses; prioritize candidate series; and guide focused optimization cycles.
AstraZeneca explores $400B combination with BMS
Why it matters: The transaction would rank among the largest pharmaceutical deals ever and create the world’s fourth-largest drugmaker by market value. It would also represent a sharp strategic turn for AstraZeneca, which has spent the past decade building its pipeline through targeted acquisitions and licensing deals rather than another industry-defining merger.